Story · Medicine & Biotech

Pharmacological enhancement of 20S proteasome-mediated degradation exposes a vulnerability in human papillomavirus (HPV)-driven cervical cancer

1 outlet · first reported by Research Square 3d ago

Coverage, in order

  1. 3d ago
    Research Square obscure study
    Pharmacological enhancement of 20S proteasome-mediated degradation exposes a vulnerability in human papillomavirus (HPV)-driven cervical cancer

    Abstract: Despite the availability of prophylactic vaccines against human papillomavirus (HPV), infection and subsequent cervical cancer remain a significant global health problem. HPV viral oncoproteins E6 and E7 drive oncogenesis, in part through disruption of cell growth control pathways via…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.